Shares of Cipla surged over 7 per cent on the Bombay Stock Exchange after the drug maker reported a consolidated net profit of Rs 1.5325 billion for the quarter ended March 31, 2018, as compared to net loss of Rs 627.9 million during year ago period.
Driven by strong Q4, stocks of the company gained as much as 7.27 per cent and touched an intra-day high of Rs 562.50 apiece on the Bombay Stock Exchange.
In a similar trend, shares of the firm were trading 1.85 per cent higher at Rs 533.70 apiece on the National Stock Exchange.
Meanwhile, the broader benchmark BSE Sensex was trading at 34,596.64, down 54.60 points, or 0.16 per cent at 11:05 hours.